Publicacións en colaboración con investigadores/as de University of Washington (3)

2023

  1. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

    The Lancet, Vol. 402, Núm. 10417, pp. 2077-2090

2009

  1. Longitudinal progression of sporadic Parkinson's disease: A multi-tracer positron emission tomography study

    Brain, Vol. 132, Núm. 11, pp. 2970-2979

2004

  1. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2)

    Movement Disorders, Vol. 19, Núm. 6, pp. 622-629